The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSyncona Share News (SYNC)

Share Price Information for Syncona (SYNC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 120.40
Bid: 120.00
Ask: 120.40
Change: -1.60 (-1.31%)
Spread: 0.40 (0.333%)
Open: 120.20
High: 121.60
Low: 120.20
Prev. Close: 122.00
SYNC Live PriceLast checked at -
Syncona is an Investment Trust

To deliver superior long-term capital appreciation from investments in life science businesses, leading long-only and alternative investment funds and managed accounts across multiple asset classes.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET MIDDAY: FTSE 100 hits 14-month high ahead of US jobs

Fri, 07th May 2021 12:13

(Alliance News) - Stock prices in London were higher at midday on Friday with the FTSE 100 returning to pre-pandemic levels, as investor attention turns to the US jobs report.

The FTSE 100 index was up 48.10 points, or 0.7%, at 7,124.34 - trading at its highest level since late February 2020 and is on track to end the week 2.4% higher.

The mid-cap FTSE 250 index was up 221.03 points, or 1.0%, at 22,712.39. The AIM All-Share index was up 0.3% at 1,256.21.

The Cboe UK 100 index was up 0.8% at 709.10. The Cboe 250 was up 1.1% at 20,398.81 and the Cboe Small Companies up 0.7% at 14,940.26.

In mainland Europe, the CAC 40 in Paris was up 0.8%, while the DAX 30 in Frankfurt was up 1.2%.

In New York, the Dow Jones Industrial Average was called up 0.3%, the S&P 500 index up 0.2%, and the Nasdaq Composite up 0.3%.

According to market consensus cited by FXStreet, the US economy is expected to have added 978,000 jobs in April, while the unemployment rate is forecast to have been reduced to 5.8% from 6.0% in March.

"European markets are looking to close out the week in positive fashion, with the FTSE 100 overcoming the 7,100 mark for the first time in 14 months. US markets helped lay the ground for today's European gains, with a welcome decline in jobless claims helping to lift spirits ahead of today's jobs report," IG Group's Josh Mahony said.

"Doubts over whether last month's payrolls figure of 916,000 was merely a temporary response to Joe Biden's USD1.9 trillion stimulus package will be answered today, with markets looking for another lofty number. Rising ADP payrolls and continued declines in the jobless claims figure does provide the basis for a possible push towards the one-million mark for today's [nonfarm payrolls] number," Mahony added.

In the FTSE 100, Barclays was up 2.6% after Sherborne Investors Management, the investment vehicle of activist investor Edward Bramson, said it has sold its entire 6.0% stake in the lender.

It ends a three-year battle between Sherborne and the London-based bank, during which the activist tried to force an exit from investment banking and the ouster of Chief Executive Jes Staley. Sherborne had called for Staley to be removed in April 2020 over his links to Jeffrey Epstein.

Based on the bank's share price on Friday, the stake is worth around GBP1.8 billion. Sherborne said it has started investing in a new target that offers a better return than Barclays. It did not identify the new target company.

InterContinental Hotels Group was up 1.0%. The Holiday Inn and Crowne Plaza owner said trading continued to improve during the first quarter of 2021.

For the three month to March 31, revenue per available room - a key metric in the hotel industry - was down 50.6% from the same time in 2019 and down 33.7% versus 2020.

IHG noted there was a notable pick-up in demand in March, particularly in the US and China, which continued into April. In Greater China, after temporary domestic travel restrictions were lifted, demand recovered quickly in March towards levels seen in the second half of 2020, IHG added.

International Consolidated Airlines Group was up 0.4%, overturning earlier declines. The British Airways parent posted a narrowed loss for the first quarter, but it still topped EUR1 billion.

IAG said its first quarter was badly hurt by the Covid-19 pandemic, as government restrictions and quarantine requirements grounded the travel sector. For the three months to March 31, IAG posted a pretax loss EUR1.22 billion, narrowed from EUR1.88 billion in the first quarter of 2020, as total revenue dropped 79% to EUR968 million from EUR4.59 billion.

Looking ahead, IAG said it won't be issuing profit guidance for 2021 due to uncertainty over travel restrictions.

IAG's hefty loss comes as holidaymakers from the UK will finally discover which destinations they can visit this summer without quarantining, with Portugal, Iceland and Malta among those expected to be on the travel green list.

Gibraltar and Israel could also make the cut when the list is published on Friday following weeks of speculation.

Quarantine and coronavirus testing requirements for people arriving in England once foreign holidays are permitted from May 17 will be based on a new traffic light system, with destinations placed on green, amber and red lists.

Jet engine maker Rolls-Royce was up 2.7%, ahead of the UK travel announcement. Airlines pay Rolls-Royce for engine services depending on how many hours their engines spend in the air. In addition, midcap airline and holiday stocks easyJet and Tui were up 1.7% and 2.2% respectively.

In the FTSE 250, St Modwen Properties was still the standout performer at midday, up 19% at 534.00 pence, after the property developer received a potential takeover offer worth GBP1.2 billion from US alternative asset investment firm Blackstone Group.

Blackstone has offered to acquire St Modwen for 542 pence per share in cash per share, reflecting a 21% premium to the company's closing price of 448p on Thursday, and a 24% premium to its net tangible assets per share of 437.7p as at November 30 last year.

St Modwen said it has considered the offer, and that it would be willing to recommend the offer unanimously to its shareholders should Blackstone make a firm offer. However the offer is subject to several pre-conditions, including the completion of due diligence which is currently underway.

Blackstone is required to make a firm offer by no later than the end of business on June 4.

Meggitt was the second best performer, up 8.3%, following a press report that US-based aircraft parts maker Woodward could be looking to buy its London-listed peer.

Fort Collins, Colorado-based Woodward is working with an investment bank as it mulls a potential acquisition, and Coventry, England-based Meggitt is a possible target, Reuters reported, citing an article in Dealreporter.

At the other end of the midcaps, Syncona was the worst performer, down 6.5%, after the investment firm said its portfolio company Gyroscope Therapeutics has postponed plans for its initial public offering in New York.

The pound was quoted at USD1.3924 at midday Friday, up from USD1.3876 at the London equities close Thursday, following positive UK economic data.

UK construction sector activity continued to expanded in April as easing restrictions led to a rise in new orders.

The IHS Markit-CIPS UK construction purchasing managers' index print was 61.6 points in April, little changed from 61.7 in March. The latest reading remained well above the 50.0 mark which separates expansion from contraction but missed the market forecast, cited by FXstreet, of 62.3.

On the political front, hopes of a Labour party revival under Keir Starmer suffered a blow on Friday after the Conservative party comfortably won the Hartlepool by-election for the UK Parliament.

The Leave-supporting North East constituency went blue for the first time in its 47-year-old history, as UK Prime Minister Boris Johnson demolished another brick in Labour's so-called "red wall".

Voters in the town backed Tory candidate Jill Mortimer to be their next member of Parliament over Labour's Paul Williams - an avid Remainer and second-referendum campaigner during his time as MP for Stockton South between 2017 to 2019 - in a rare by-election victory for a party in power for more than a decade.

The Conservative, who declared it a "truly historic result", secured a 6,940 majority winning 15,529 votes to Williams's 8,589.

Elsewhere, Scottish National Party leader Nicola Sturgeon's push for a second independence referendum means the stakes are high in the contest for the devolved Scottish Parliament. Results from the Holyrood election will come through later on Friday and Saturday.

The SNP is expected to emerge again as the largest party in the Scottish Parliament after the election, but it wants to win an overall majority of MSPs as it pushes for a second vote on splitting from the Union - something which polls suggest remains in the balance.

"UK breakup remains a tail risk underpriced by the market but one that can probably be confidently kicked down the road for at least eight years - the current Tory government won't grant a referendum. Today's Hartlepool by-election result underlines how far Labour still need to travel to mount any kind of challenge to Boris at the next election," commented Markets.com analyst Neil Wilson.

The euro was priced at USD1.2065, up from USD1.2053. Against the yen, the dollar was trading at JPY109.08, flat from JPY109.09.

Brent oil was quoted at USD68.53 a barrel Friday at midday, up from USD68.39 late Thursday. Gold was quoted at USD1,819.25 an ounce, higher against USD1,813.85.

By Arvind Bhunjun; arvindbhunjun@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
14 Nov 2023 11:29

IN BRIEF: Syncona notes investee company's quarterly loss

Syncona Ltd - London-based investor in healthcare companies - Says portfolio company Achilles Therapeutics reports that pretax loss widened to USD16.7 million in the third quarter of 2023 from USD12.4 million the year before, as operating expenses rose 19% to USD19.1 million from USD16.0 million a year ago. Achilles is a Philadelphia, US-based clinical-stage biopharmaceutical company which develops novel cancer immunotherapies. Syncona owns a 25% stake in Achilles.

Read more
9 Nov 2023 15:44

UK earnings, trading statements calendar - next 7 days

Friday 10 November 
Allianz Technology Trust PLCQ3 Results
Wheaton Precious Metals CorpQ3 Results
Monday 13 November 
Bank of Cyprus Holdings PLCQ3 Results
British Land Co PLCHalf Year Results
Kainos Group PLCHalf Year Results
Team Internet Group PLCQ3 Results
Tuesday 14 November 
ActiveOps PLCHalf Year Results
Babcock International Group PLCHalf Year Results
Bank of Georgia Group PLCQ3 Results
Castings PLCHalf Year Results
ConvaTec Group PLCTrading Statement
DCC PLCHalf Year Results
Forterra PLCHalf Year Results
Gear4Music PLCHalf Year Results
Genel Energy PLCTrading Statement
HydrogenOne Capital Growth PLCQ3 Results
Hill & Smith PLCTrading Statement
Imperial Brands PLCFull Year Results
Informa PLCTrading Statement
Land Securities Group PLCHalf Year Results
Oxford Instruments PLCHalf Year Results
Picton Property Income LtdHalf Year Results
Renalytix PLCQ1 Results
Vesuvius PLCTrading Statement
Vodafone Group PLCHalf Year Results
Wise PLCHalf Year Results
Wednesday 15 November 
Diversified Energy Co PLCTrading Statement
Experian PLCHalf Year Results
Fuller, Smith & Turner PLCHalf Year Results
Genuit Group PLCTrading Statement
Intermediate Capital Group PLCHalf Year Results
Ninety One PLC and LtdHalf Year Results
Renold PLCHalf Year Results
SSE PLCHalf Year Results
Synthomer PLCTrading Statement
Tracsis PLCFull Year Results
Tullow Oil PLCTrading Statement
Warehouse REIT PLCHalf Year Results
Thursday 16 November 
Assura PLCHalf Year Results
Atalaya Mining PLCQ3 Results
Aviva PLCTrading Statement
Burberry Group PLCHalf Year Results
Close Brothers Group PLCTrading Statement
CMC Markets PLCHalf Year Results
Crest Nicholson Holdings PLCTrading Statement
Halma PLCHalf Year Results
Great Portland Estates PLCHalf Year Results
Kier Group PLCTrading Statement
International Distributions Services PLCHalf Year Results
Investec PLC and LtdHalf Year Results
Liontrust Asset Management PLCHalf Year Results
Manolete Partners PLCHalf Year Results
Melrose Industries PLCTrading Statement
Norcros PLCHalf Year Results
Premier Foods PLCHalf Year Results
Qinetiq Group PLCHalf Year Results
Spirax-Sarco Engineering PLCTrading Statement
Syncona LtdHalf Year Results
Tatton Asset Management PLCHalf Year Results
Tyman PLCTrading Statement
United Utlities Group PLCHalf Year Results
Young & Co's Brewery PLCHalf Year Results
  
Copyright 2023 Alliance News Ltd. All Rights Reserved.

Read more
3 Nov 2023 11:51

TRADING UPDATES: Augmentum Fintech makes further investment in Tide

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday, Thursday and Friday and not separately reported by Alliance News:

Read more
18 Oct 2023 12:01

IN BRIEF: Syncona announces takeover offer for Freeline Therapeutics

Syncona Ltd - London-based investor in healthcare companies - Says Syncona Investment Management Ltd has submitted a non-binding proposal to acquire the entire remaining share capital of Freeline Therapeutic Holdings PLC. Offers upfront cash consideration of USD5.00 per American depository share, representing a 20% premium over the USD4.16 volume weighted average price from October 4 to October 16. Syncona currently owns around 57.9% of shares in Stevenage, England-based Freeline, which it co-founded in 2015. Freeline aims to develop gene therapies to treat chronic diseases, most notably its potentially "transformative" FLT201 programme to treat Gaucher disease.

Read more
4 Oct 2023 14:28

Syncona says Freeline and SwanBio clinical trails make progress

(Alliance News) - Syncona Ltd on Wednesday said its portfolio company Freeline Therapeutics Holdings PLC has received positive initial safety, tolerability and enzyme activity data from its FLT201 trial for the treatment of Gaucher disease.

Read more
29 Sep 2023 09:51

IN BRIEF: Syncona launches GBP40 million share buyback programme

Syncona Ltd - London-based investor in healthcare companies - Launches share buyback programme worth up to GBP40.0 million, to be conducted by Numis Securities Ltd. Says core focus remains on allocating capital to portfolio companies' assets. However the buyback is necessary due to Syncona's shares currently trading at a discount to net asset value, which was 184.6 pence per share at June 30. Says buyback will not affect investments into clinical stage assets planned for the next 24 months. Company expects that capital deployment into portfolio and pipeline will total between GBP150 million and GBP200 million for the year ending March 31, in line with prior guidance. Chair Melanie Gee says Syncona "has a high level of confidence in our portfolio and its valuation".

Read more
11 Sep 2023 15:42

Syncona shares slump as Novartis ends eye treatment development

(Sharecast News) - Syncona shares fell as the UK healthcare investment firm said Novartis had stopped the development of experimental eye treatment, GT005, resulting in milestone payments write-off of £54.5m for Gyroscope Holdings in which Syncona once held a 54% stake.

Read more
11 Sep 2023 09:51

Syncona suffers negative valuation hit as Novartis discontinues GT005

(Alliance News) - Syncona Ltd on Monday said it has been informed by Swiss-American pharmaceutical company Novartis AG that the development of eye treatment, GT005, for geographic atrophy secondary to dry age-related macular degeneration will be discontinued.

Read more
11 Sep 2023 07:54

LONDON BRIEFING: Restaurant Group sells Frankie & Benny's and Chiquito

(Alliance News) - Stocks in London are called higher on Monday, ahead of a busy week of interest rate decisions and economic data.

Read more
15 Aug 2023 13:56

IN BRIEF: Syncona notes clinical progress of portfolio firm Freeline

Syncona Ltd - London-based healthcare investor - Notes second quarter results announcement from its Nasdaq-listed portfolio company Freeline Therapeutics Holdings PLC. Says the key highlights include Freeline completing the dosing in the first dose cohort of the phase 1/2 trial of FLT201 in Gaucher disease, following dosing of the second patient. Says initial clinical data from the FLT201 trial is expected in the second half of 2023. Also says Freeline has a cash position of USD38.8 million at June 30 compared to USD55.4 million on March 31, which Freeline expects will enable the company to fund its planned operations into the second quarter of 2024. Freeline says net income in the three months that ended June 30 narrowed to USD14.8 million from USD51.1 million a year earlier.

Read more
10 Aug 2023 09:33

IN BRIEF: Syncona says net asset value slips 1% in first quarter

Syncona Ltd - London-based healthcare investor - Net asset value at June 30 is 184.6 pence per share, down 1.0% from 186.5p on March 31. NAV total return also was negative 1.0% for the recent three months, Syncona's financial first quarter. Notes performance was hurt by "negative foreign exchange movements" across its life science portfolio. This is valued at GBP628.7 million on June 30, up 4.0% from GBP604.6 million on March 31.

Read more
10 Aug 2023 08:34

Syncona reports slight dip in net assets

(Sharecast News) - Healthcare investor Syncona reported a slight dip in net assets in its quarterly update on Thursday, to £1.24bn, down from £1.26bn at the end of March.

Read more
4 Aug 2023 14:09

IN BRIEF: Syncona's portfolio Achilles Therapeutics net loss narrows

Syncona Ltd - Healthcare company focused on developing its life science portfolio - Notes its portfolio company Archilles Therapeutics PLC's net loss in its second quarter ended June 30 narrows 2.9% to USD16.8 million, from USD17.3 million year-on-year. Cash and cash equivalents are "strong", standing at USD143.7 million on June 30, down 17% from USD173.3 million on December 31. Research & development expenses increase are USD13.8 million, down 6.8% from USD14.8 million at the same point the year prior. Archilles Therapeutics's general & administrative expenses were USD4.3 million, down 26% from USD5.8 million the year before, driven by a change in cost allocations and lower professional fees.

Read more
25 Jul 2023 15:47

UK shareholder meetings calendar - next 7 days

Wednesday 26 July 
Aquila Services Group PLCAGM
Blackstone Loan Financing LtdAGM
BP Marsh & Partners PLCAGM
Eurasia Mining PLCAGM
Molten VenturesAGM
Motorpoint Group PLCAGM
NewRiver REIT PLCAGM
Ninety One PLC and LtdAGM
Norcros PLCAGM
Oracle Power PLCAGM
Palace Capital PLCAGM
ProBiotix Health PLCAGM
Seeen PLCAGM
Silverwood Brands PLCAGM
Triad Group PLCAGM
Water Intelligence PLCAGM
Zephyr Energy PLCAGM
Thursday 27 July 
Foresight Group Holdings LtdAGM
Marks Electrical Group PLCAGM
Silver Bullet Data Services Group PLCAGM
Friday 28 July 
African Pioneer PLCAGM
Bezant Resources PLCAGM
Braveheart Investment Group PLCAGM
Cordiant Digital Infrastructure LtdAGM
DP Poland PLCAGM
Intuitive Investments Group PLCGM re proposals on investment strategy
Jangada Mines PLCAGM
Mercantile Ports & Logistics LtdAGM
MetalNRG PLCAGM
Northern 2 VCT PLCGM re party transaction
Polymetal International PLCGM re delisting
R&Q Insurance Holdings LtdAGM
Science in Sport PLCAGM
Urban Logistics REIT PLCAGM
Xtract Resources PLCAGM
Monday 31 July 
B90 Holdings PLCAGM
Barryroe Offshore Energy PLCEGM re proposed cancellation of admission to trading on AIM
Live Co Group PLCAGM
OnTheMarket PLCAGM
Tintra PLCAGM
Tuesday 1 August 
Bonhill Group PLCGM re members' voluntary liquidation
Deltex Medical Group PLCGM re placing and subscription
Syncona LtdAGM
  
Copyright 2023 Alliance News Ltd. All Rights Reserved.

Read more
15 Jun 2023 08:44

Syncona net asset value falls as cites economic uncertainty, inflation

(Alliance News) - Syncona Ltd on Thursday reported a lower net asset value per share at the end of March amid a "challenging" backdrop for the biotechnology companies, citing inflation and economic uncertainty.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.